Trump responds after Dilbert creator Scott Adams pleads for his help to save his life

President Donald Trump responded to a plea for help from cancer-stricken cartoonist Scott Adams.

The “Dilbert” creator and Trump supporter updated in a social media post that he is “declining fast” from the metastasized prostate cancer and needs the president’s help in scheduling a drug treatment that could help in his battle.

Trump and Health and Human Services Secretary Robert F. Kennedy Jr. responded to Adams on X, as did Dan Scavino, the White House deputy chief of staff, after the 68-year-old author explained how his healthcare provider, Kaiser Permanente – Northern California, had “dropped the ball.”

“On Monday, I will ask President Trump, via X, to help save my life. He offered to help me if I needed it,” Adams wrote. “I need it.”

“My healthcare provider, Kaiser of Northern California, has approved my application to receive a newly FDA-approved drug called Pluvicto. But they have dropped the ball in scheduling the brief IV to administer it, and I can’t seem to fix that,” Adams wrote.

“I am declining fast. I will ask President Trump if he can get Kaiser of Northern California to respond and schedule it for Monday. That will give me a fighting chance to stick around on this planet a little bit longer,” he added.

ADVERTISEMENT

“It is not a cure, but it does give good results to many people,” Adams concluded.

Among the many responses wishing him well and sending prayers, Adams got the attention of the president himself.

“On it!” Trump posted on Truth Social on Sunday.

Others also responded to the plea, assuring the cartoonist that the president would act on his behalf.

ADVERTISEMENT

“Scott. How do I reach you? The President wants to help,” RFK Jr. wrote.

“Going to make sure that my dad sees this. We’re all praying for you, keep fighting!” the president’s son, Don Jr., posted.

“No need till [sic] wait until Monday—@realDonaldTrump, @RobertKennedyJr, and @DrOz are all tracking now, Scott,” Scavino assured.

ADVERTISEMENT

“Mr. Adams’ oncology team is working closely with him on the next steps in his cancer care, which are already underway,” Kaiser Permanente said in a statement, according to Fox News Digital. “Since it was approved by the FDA three years ago, Kaiser Permanente’s nuclear medicine and medical oncology experts have treated more than 150 patients with Lu-177 PSMA (Pluvicto) in Northern California alone. We know this drug and this disease.”

Adams shared the shocking news about the cancer in a May episode of his podcast. This came shortly after former President Joe Biden revealed he also had prostate cancer.

Frieda Powers

Comment

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.

Latest Articles